Evidence map›Paper›PMID 40262372›Full record

ArticleVaccine2025

Fluorescence-barcoded cell lines stably expressing membrane-anchored influenza neuraminidases.

Joel Finney, Masayuki Kuraoka, Shengli Song, Akiko Watanabe, Xiaoe Liang, Dongmei Liao, M Anthony Moody, Emmanuel B Walter, Stephen C Harrison, Garnett Kelsoe

Abstract read
In one paragraph

Article in Vaccine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Joel FinneyLaboratory of Molecular Medicine, Children's Hospital, Harvard Medical School, Boston, MA 02115, USA. Electronic address: jfinney@crystal.harvard.edu.
Masayuki KuraokaDepartment of Integrative Immunobiology, Duke University, Durham, NC 27710, USA.
Shengli SongDepartment of Surgery, Duke University, Durham, NC 27710, USA.
Akiko WatanabeDepartment of Integrative Immunobiology, Duke University, Durham, NC 27710, USA.
Xiaoe LiangDepartment of Integrative Immunobiology, Duke University, Durham, NC 27710, USA.
Dongmei LiaoDepartment of Integrative Immunobiology, Duke University, Durham, NC 27710, USA.
M Anthony MoodyDepartment of Integrative Immunobiology, Duke University, Durham, NC 27710, USA; Department of Pediatrics, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University, Durham, NC 27710, USA.
Emmanuel B WalterDepartment of Pediatrics, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University, Durham, NC 27710, USA.
Stephen C HarrisonLaboratory of Molecular Medicine, Children's Hospital, Harvard Medical School, Boston, MA 02115, USA; Howard Hughes Medical Institute, Boston, MA 02115, USA. Electronic address: harrison@crystal.harvard.edu.
Garnett KelsoeDepartment of Integrative Immunobiology, Duke University, Durham, NC 27710, USA; Department of Surgery, Duke University, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University, Durham, NC 27710, USA.

Funding

Virology CoreP01AI089618 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI STEPHEN COPLAN HARRISON · 2011 to 2026
$40.0M
Howard Hughes Medical InstituteNIAID NIH HHS P01 AI089618
6 · The paper itself

Abstract

The discovery of broadly protective antibodies to the influenza virus neuraminidase (NA) has raised interest in NA as a vaccine target. However, recombinant, solubilized tetrameric NA ectodomains are often challenging to express and isolate, hindering the study of anti-NA humoral responses. To address this obstacle, we established a panel of 22 non-adherent cell lines stably expressing native, historical N1, N2, N3, N9, and NB NAs anchored on the cell surface. The cell lines are barcoded with fluorescent proteins, enabling high-throughput, 16-plex analyses of antibody binding with commonly available flow cytometers. The cell lines were at least as efficient as a Luminex multiplex binding assay at identifying NA antibodies from a library of unselected clonal IgGs derived from human memory B cells. The cell lines were also useful for measuring the magnitude and breadth of the serum antibody response elicited by experimental infection of rhesus macaques with influenza virus. The membrane-anchored NAs are catalytically active and are compatible with established sialidase activity assays. NA-expressing K530 cell lines therefore represent a useful tool for studying NA immunity and evaluating influenza vaccine efficacy.

Indexed as

NeuraminidaseViral ProteinsAnimalsAntibodies, ViralCell LineFlow CytometryHumansImmunoglobulin GInfluenza VaccinesMacaca mulattaOrthomyxoviridae InfectionsAntibodies, ViralImmunoglobulin GInfluenza VaccinesNeuraminidaseViral ProteinsBarcodeBarcodingBinding assaysELLAFlow cytometryFluorescent proteinImmunoassayNA-Star assaySialidaseVaccine

Identifiers

PMID40262372
PMCPMC12086040

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.